Stay updated on Personalized Neoantigen Cancer Vaccine Clinical Trial
Sign up to get notified when there's something new on the Personalized Neoantigen Cancer Vaccine Clinical Trial page.

Latest updates to the Personalized Neoantigen Cancer Vaccine Clinical Trial page
- Check5 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study page still displays a 403 error.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedFDA-regulated product disclosures and a large set of drug/MeSH terms (including ipilimumab and nivolumab) were deleted. The deletions reduce visibility of the study’s immunotherapy components and regulatory context on the page.SummaryDifference19%

- Check40 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a new page build/version. This change represents a metadata update and does not modify study content or user-facing information.SummaryDifference0.0%

- Check54 days agoChange DetectedA minor version update was applied, changing the page revision from v3.6.5 to v3.6.6. The visible content and study details remain unchanged.SummaryDifference0.0%

- Check75 days agoChange DetectedThe revision badge on the page has been updated from v3.6.4 to v3.6.5, representing a small software version update. It does not modify study details or visible content.SummaryDifference0.0%

Stay in the know with updates to Personalized Neoantigen Cancer Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Personalized Neoantigen Cancer Vaccine Clinical Trial page.